デフォルト表紙
市場調査レポート
商品コード
1630683

脳神経外科市場規模、シェア、成長分析、製品別、年齢層別、適応症別、流通チャネル別、エンドユーザー別、地域別-2025-2032年産業予測

Neurosurgery Market Size, Share, Growth Analysis, By Product (Neuro Interventional Devices, Neuroendoscopes), By Age Group (Pediatric, Adult), By Indication, By Distribution Channel, By End-user, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
脳神経外科市場規模、シェア、成長分析、製品別、年齢層別、適応症別、流通チャネル別、エンドユーザー別、地域別-2025-2032年産業予測
出版日: 2025年01月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

脳神経外科の世界市場規模は、2023年に43億米ドルと評価され、2024年の45億米ドルから2032年には64億5,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは4.6%で成長する見通しです。

世界の脳神経外科市場は、いくつかの重要な要因によって大きな成長を遂げています。脳神経外科手術の技術革新と機器の進歩により、より精密で低侵襲な手術が可能になり、患者の予後が向上し、回復時間が短縮されました。高齢化人口の増加と神経疾患の増加により、神経外科的介入に対する需要が高まっています。さらに、医療機関と製薬会社の提携が治療法の革新を促進しています。しかし、同市場は専門的なトレーニングや高価な機器の必要性から参入障壁が高く、新規参入者にとって課題となっています。全体として、脳神経外科市場は、世界人口の進化するヘルスケア需要に適応しながら、継続的な拡大が見込まれています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ分析

脳神経外科市場規模:製品別

  • 市場概要
  • 神経介入デバイス
  • 神経内視鏡
  • 脳神経外科用ドリル
  • 放射線手術システム
  • 硬膜代替品
  • 脳神経外科用アブレーション装置
  • 脳神経外科機器

脳神経外科市場規模:年齢層別

  • 市場概要
  • 小児
  • 成人
  • 老年

脳神経外科市場規模:適応症別

  • 市場概要
  • 脳腫瘍
  • 脊椎および頭蓋底腫瘍
  • 外傷性脳損傷
  • 頭蓋顔面外傷
  • パーキンソン病
  • トゥレット症候群
  • その他

脳神経外科市場規模:流通チャネル別

  • 市場概要
  • 直接入札
  • サードパーティの販売業者
  • その他

脳神経外科市場規模:エンドユーザー別

  • 市場概要
  • 病院と専門クリニック
  • 外来手術センター
  • その他

脳神経外科市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Elekta(Sweden)
  • ALEVA NEUROTHERAPEUTICS(Switzerland)
  • Machida Endoscope Co., Ltd.(Japan)
  • Brainlab AG(Germany)
  • adeor medical AG.(Germany)
  • LivaNova PLC(UK)
  • B. Braun SE(Germany)
  • Optofine Instruments Pvt. Ltd.(India)
  • Wallaby Medical(Australia)
  • Terumo Medical Corporation(Japan)
  • NEVRO CORP.(US)
  • Integra LifeSciences(US)
  • Stryker(US)
  • Penumbra, Inc.(US)
  • KARL STORZ SE & Co. KG(Germany)
  • Nalu Medical, Inc.(US)
  • Renishaw plc.(UK)
  • Synapse Biomedical Inc.(US)
  • EMS Handels Gesellschaft mbH(Germany)
  • Inomed Medizintechnik GmbH(Germany)

結論と推奨事項

目次
Product Code: SQMIG35G2274

Global Neurosurgery Market size was valued at USD 4.3 billion in 2023 and is poised to grow from USD 4.5 billion in 2024 to USD 6.45 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The global neurosurgery market is experiencing significant growth, fueled by several key factors. Technological innovations in neurosurgical techniques and equipment have led to more precise and minimally invasive procedures, enhancing patient outcomes and shortening recovery times. The increasing aging population coupled with a rise in neurological conditions has heightened the demand for neurosurgical interventions. Furthermore, partnerships between medical institutions and pharmaceutical companies are driving innovation in treatment options. However, the market faces high entry barriers due to the need for specialized training and expensive equipment, presenting challenges for newcomers. Overall, the neurosurgery market is set for continued expansion as it adapts to the evolving healthcare demands of a global population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurosurgery Market Segmental Analysis

Global Neurosurgery Market is segmented by Product, Age Group, Indication, Distribution Channel, End-user and region. Based on Product, the market is segmented into Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes, Neurosurgical Ablation Devices and Neurosurgery Instruments. Based on Age Group, the market is segmented into Pediatric, Adult and Geriatric. Based on Indication, the market is segmented into Brain Cancer, Spine and Skull base Tumors, Traumatic Brain Injuries, Craniofacial Trauma, Parkinson's Disease, Tourette's Syndrome and Others. Based on Distribution Channel, the market is segmented into Direct tender, Third party distributors and Others. Based on End-user, the market is segmented into Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurosurgery Market

The global neurosurgery market is significantly influenced by technological advancements, which serve as a primary driver of growth. Innovations such as artificial intelligence, 5G connectivity, and the Internet of Things (IoT) are transforming the healthcare landscape by enhancing operational efficiency and unlocking new market opportunities. These cutting-edge technologies not only augment product capabilities but also elevate patient experiences, thereby propelling market expansion. As they pave the way for novel revenue streams, their integration into neurosurgery practices is set to revolutionize the industry, making it more responsive to both provider and patient needs while fostering continuous innovation and development.

Restraints in the Global Neurosurgery Market

Regulatory compliance challenges stand as a significant restraint within the Global Neurosurgery market. The ever-evolving and complex nature of regulations, particularly in sectors such as healthcare and finance, can hinder product development and limit market access. Companies frequently encounter substantial costs associated with compliance and the risk of penalties for failing to adhere to regulations. This environment necessitates that businesses effectively manage and navigate these regulatory obstacles in order to succeed in the competitive landscape of the neurosurgery market. Successfully addressing these challenges is crucial for fostering innovation and achieving sustainable growth within the industry.

Market Trends of the Global Neurosurgery Market

The global neurosurgery market is witnessing a significant trend towards minimally invasive surgical techniques, driven by a heightened demand for procedures that reduce patient risk and accelerate recovery. Advances in technology, particularly in robotic surgery and imaging guidance, are enhancing the precision and effectiveness of these methods. Patients and healthcare providers alike are increasingly favoring these minimally invasive options, as they offer lower complication rates and shorter hospital stays. This shift is expected to shape the neurosurgery landscape, leading to greater adoption of innovative techniques and technologies that improve surgical outcomes, ultimately contributing to market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Study Analysis

Global Neurosurgery Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Neuro Interventional Devices
  • Neuroendoscopes
  • Neurosurgical Drills
  • Radiosurgery Systems
  • Dura Substitutes
  • Neurosurgical Ablation Devices
  • Neurosurgery Instruments

Global Neurosurgery Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Pediatric
  • Adult
  • Geriatric

Global Neurosurgery Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Brain Cancer
  • Spine and Skull base Tumors
  • Traumatic Brain Injuries
  • Craniofacial Trauma
  • Parkinson's Disease
  • Tourette's Syndrome
  • Others

Global Neurosurgery Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Direct tender
  • Third party distributors
  • Others

Global Neurosurgery Market Size by End-user & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Global Neurosurgery Market Size & CAGR (2025-2032)

  • North America (Product, Age Group, Indication, Distribution Channel, End-user)
    • US
    • Canada
  • Europe (Product, Age Group, Indication, Distribution Channel, End-user)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Age Group, Indication, Distribution Channel, End-user)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Age Group, Indication, Distribution Channel, End-user)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Age Group, Indication, Distribution Channel, End-user)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Elekta (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ALEVA NEUROTHERAPEUTICS (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Machida Endoscope Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Brainlab AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • adeor medical AG. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optofine Instruments Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wallaby Medical (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Medical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NEVRO CORP. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • KARL STORZ SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nalu Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Renishaw plc. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synapse Biomedical Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMS Handels Gesellschaft mbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inomed Medizintechnik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations